Skip to main content

Inflammasomes: Clinical and Therapeutic Implications

  • Book
  • © 2018

Overview

  • Extensive coverage of the roles played by inflammasomes in various diseases
  • Examines the inflammasome as a potential therapeutic target
  • Discusses pharmacological developments in inflammasome inhibition

Part of the book series: Experientia Supplementum (EXS, volume 108)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

Keywords

About this book

The inflammasome is a protein complex composed of an intracellular sensor—typically a Nod-like receptor (NLR), the precursor procaspase-1, and the adaptor ASC. Inflammasome activation leads to the maturation of caspase-1 and the processing of its substrates, IL-1β and IL-18. The inflammasome has been implicated numerous diseases, and blockade of inflammasome-derived IL-1β has beneficial effects on several of these diseases. Different books have been edited about the biology of inflammasomes and about methods to study, however, the implication of this complex in the different diseases and pathological conditions show the need of a book about the clinical implications and therapeutic options. This project will show the context where inflammasomes are being studied and the molecular implications in the medical and clinical contexts.

Other important topic of the inflammasomes will be the development of pharmacological inhibitors in order to improve new clinical applications. In this sense, we can find new drugs with inhibitory effects or old drugs with an inhibitory potential effect. There is a need for re-establishing the real benefits of the inflammasome inhibitions in pathological situations and the management of the differents diseases where inflammasomes are implicated.

Editors and Affiliations

  • Department of Physiology, Institute of Nutrition and Food Technology “José Mataix”, Biomedical Research Center (CIBM), University of Granada, Armilla, Spain

    Mario D. Cordero

  • Departamento de Psicología Experimental, Facultad de Psicología, Universidad de Sevilla, Seville, Spain

    Elísabet Alcocer-Gómez

About the editors

Mario D Cordero is Research Associate at the University of Sevilla. He studies the role of inflammasomes in metabolic and cardiovascular diseases, with special attention on the implication of NLRP3 in age-associated diseases. He is also involved in the evaluation of inflammasome inhibitors in rare diseases.Dr Cordero is one of the editors of volume no. 107 on AMP-activated protein kinases in the same series.  


Elísabet Alcocer-Gómez is Research Associate at the University of Sevilla. Her scientific interest is the implication of inflammasome complexes in psychiatric diseases and the effect of psychiatric drugs on the inhibition or induction of inflammasome activation. 


Bibliographic Information

  • Book Title: Inflammasomes: Clinical and Therapeutic Implications

  • Editors: Mario D. Cordero, Elísabet Alcocer-Gómez

  • Series Title: Experientia Supplementum

  • DOI: https://doi.org/10.1007/978-3-319-89390-7

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer International Publishing AG, part of Springer Nature 2018

  • Hardcover ISBN: 978-3-319-89389-1Published: 17 September 2018

  • Softcover ISBN: 978-3-030-07758-7Published: 03 January 2019

  • eBook ISBN: 978-3-319-89390-7Published: 04 September 2018

  • Series ISSN: 1664-431X

  • Series E-ISSN: 2504-3692

  • Edition Number: 1

  • Number of Pages: VIII, 400

  • Number of Illustrations: 37 b/w illustrations, 26 illustrations in colour

  • Topics: Molecular Medicine, Medical Biochemistry

Publish with us